Old Web
English
Sign In
Acemap
>
Paper
>
PIH10 COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA
PIH10 COST-EFFECTIVENESS ANALYSIS OF IMRECOXIB, CELECOXIB AND DICLOFENAC IN OSTEOARTHRITIS IN CHINA
2020
Xin Sun
X. Hu
X. Zhen
Y. Gu
Zhi-Mei Zhao
Hengjin Dong
Keywords:
Diclofenac
Intensive care medicine
Cost-effectiveness analysis
Osteoarthritis
Medicine
Celecoxib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]